Brief: Mink Therapeutics Posts Q2 Loss Per Share $0.18
09/08/2022 14:50
Aug 9 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK THERAPEUTICS REPORTS CORPORATE UPDATE AND SECOND
QUARTER
2022 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.18
Source text for Eikon: ID:nGNX3yN1bm
Further company coverage: INKT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's